What is the share price of Dipna Pharmachem Ltd (DPL) today?
The share price of DPL as on 14th July 2025 is ₹25.50. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Dipna Pharmachem Ltd (DPL) share?
The past returns of Dipna Pharmachem Ltd (DPL) share are- Past 1 week: 10.52%
- Past 1 month: 17.73%
- Past 3 months: 54.92%
- Past 6 months: 68.76%
- Past 1 year: 223.60%
- Past 3 years: N/A%
- Past 5 years: -7.08%
What are the peers or stocks similar to Dipna Pharmachem Ltd (DPL)?
The peers or stocks similar to Dipna Pharmachem Ltd (DPL) include:What is the market cap of Dipna Pharmachem Ltd (DPL) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Dipna Pharmachem Ltd (DPL) is ₹61.32 Cr as of 14th July 2025.What is the 52 week high and low of Dipna Pharmachem Ltd (DPL) share?
The 52-week high of Dipna Pharmachem Ltd (DPL) is ₹26.31 and the 52-week low is ₹6.40.What is the PE and PB ratio of Dipna Pharmachem Ltd (DPL) stock?
The P/E (price-to-earnings) ratio of Dipna Pharmachem Ltd (DPL) is 63.21. The P/B (price-to-book) ratio is 1.63.Which sector does Dipna Pharmachem Ltd (DPL) belong to?
Dipna Pharmachem Ltd (DPL) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Dipna Pharmachem Ltd (DPL) shares?
You can directly buy Dipna Pharmachem Ltd (DPL) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Dipna Pharmachem Ltd
DPL Share Price
25.500.00% (+0.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
DPL Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
BadThe stock is in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
DPL Performance & Key Metrics
DPL Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 1.63 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 37.43 | 6.45 | 0.80% |
DPL Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
DPL Company Profile
Dipna Pharmachem Limited trades and imports pharmaceutical raw materials and active ingredients, assisting in contract manufacturing compliance.
SUNPHARMA
PE Ratio
36.94
36.94
1Y Return
6.08%
6.08%
Buy Reco %
87.10
87.10
CIPLA
PE Ratio
22.73
22.73
1Y Return
2.19%
2.19%
Buy Reco %
73.33
73.33
TORNTPHARM
PE Ratio
60.29
60.29
1Y Return
15.28%
15.28%
Buy Reco %
70.83
70.83
MANKIND
PE Ratio
55.89
55.89
1Y Return
25.50%
25.50%
Buy Reco %
81.25
81.25
DRREDDY
PE Ratio
18.40
18.40
1Y Return
7.97%
7.97%
Buy Reco %
50.00
50.00
DPL Forecast
DPL Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
DPL
DPL
Income
Balance Sheet
Cash Flow
Annual Normal View
DPL Income Statement
DPL Income Statement
Annual Normal View
| Financial Year | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 16.57 | 20.19 | 30.55 | 31.02 | 72.77 | 99.94 | 164.34 | 124.93 | — | |||||||||
Raw Materials | 17.08 | 17.52 | 31.16 | 31.22 | 67.67 | 108.13 | 176.35 | 121.48 | — | |||||||||
| Power & Fuel Cost | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |||||||||||
| Employee Cost | 0.00 | 0.00 | 0.38 | 0.41 | 0.00 | 0.00 | 0.00 | |||||||||||
| Selling & Administrative Expenses | 0.70 | 0.63 | 0.61 | 0.54 | 1.66 | 1.92 | 2.77 | |||||||||||
| Operating & Other expenses | -1.62 | 1.53 | -2.07 | -1.57 | 1.25 | -12.48 | -18.24 | |||||||||||
EBITDA | 0.40 | 0.50 | 0.47 | 0.42 | 2.19 | 2.37 | 3.45 | 3.45 | — | |||||||||
| Depreciation/Amortization | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | — | |||||||||
| PBIT | 0.40 | 0.49 | 0.46 | 0.41 | 2.18 | 2.36 | 3.43 | 3.44 | — | |||||||||
| Interest & Other Items | 0.33 | 0.43 | 0.39 | 0.35 | 0.61 | 0.97 | 2.01 | 2.02 | — | |||||||||
| PBT | 0.07 | 0.06 | 0.07 | 0.06 | 1.57 | 1.39 | 1.42 | 1.42 | — | |||||||||
| Taxes & Other Items | 0.01 | 0.02 | 0.00 | 0.03 | 0.41 | 0.47 | 0.34 | 0.45 | — | |||||||||
| Net Income | 0.06 | 0.04 | 0.07 | 0.03 | 1.16 | 0.92 | 1.08 | 0.97 | — | |||||||||
| EPS | 2.93 | 1.96 | 3.42 | 1.47 | 56.74 | 1.25 | 0.56 | 0.41 | — | |||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | |||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
DPL Company Updates
DPL Stock Peers
DPL Past Performance & Peer Comparison
DPL Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation-basic on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Dipna Pharmachem Ltd | 63.21 | 1.63 | — |
| Sun Pharmaceutical Industries Ltd | 36.94 | 5.57 | 0.95% |
| Cipla Ltd | 22.73 | 3.83 | 1.08% |
| Torrent Pharmaceuticals Ltd | 60.29 | 15.18 | 0.94% |
DPL Stock Price Comparison
Compare DPL with any stock or ETFCompare DPL with any stock or ETF
DPL
DPL Holdings
DPL Shareholdings
DPL Promoter Holdings Trend
DPL Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
DPL Institutional Holdings Trend
DPL Institutional Holdings Trend
No institutional holdings trend are available
DPL Shareholding Pattern
DPL Shareholding Pattern
DPL Shareholding History
DPL Shareholding History
Foreign Institutions
smallcases containing DPL stock
smallcases containing DPL stock
Looks like this stock is not in any smallcase yet.
DPL Events
DPL Events
DPL Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
DPL has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
DPL Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
DPL has not given any dividends in last 5 years
DPL Dividends
DPL Dividends
Hmm, looks like data is unavailable here. Please come back after some timeDPL Stock News & Opinions
DPL Stock News & Opinions
Articles & Videos
Corporate
Dipna Pharmachem to announce Quarterly Result
Dipna Pharmachem will hold a meeting of the Board of Directors of the Company on 7 July 2025.Powered by Capital Market - Live
1 week agoCapital Market - Live
Corporate
Dipna Pharmachem EGM scheduled
Dipna Pharmachem announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 4 April 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Dipna Pharmachem to hold board meeting
Dipna Pharmachem will hold a meeting of the Board of Directors of the Company on 12 March 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Dipna Pharmachem announces board meeting date
Dipna Pharmachem will hold a meeting of the Board of Directors of the Company on 24 February 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Dipna Pharmachem to convene board meeting
Dipna Pharmachem will hold a meeting of the Board of Directors of the Company on 6 February 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Dipna Pharmachem announces board meeting date
Dipna Pharmachem will hold a meeting of the Board of Directors of the Company on 29 July 2024.Powered by Capital Market - Live
11 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 32.54%, vs industry avg of 10.04%
Over the last 5 years, market share increased from 0.01% to 0.03%
Over the last 5 years, net income has grown at a yearly rate of 69.17%, vs industry avg of 19.67%